Leukemia, Lymphoma, rhabdomyosarcoma, Immuno deficiency, CAEBV, hematological disease, auto immune disease, collagen disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The consalt and permission from doctor for mrimary disease, long term survive is expected, the high risk of ovarian dysfunction due to therapy for primary disease, operable condition
Exclusion criteria
Exclusion criteria: No consult and permission from primary doctor, long term survival is not expected, no gonadal risk, very poor general condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety of surgery(operation time, blood loss, complication),the numbers of ovarian cortex, the numbers of retrieved oocyte | — |
Secondary
| Measure | Time frame |
|---|---|
| The existance of minimal residual disease | — |
Countries
Japan
Contacts
St. Marianna University School of Medicine Department of Obstetrics and Gynecology